• Antibodies to HHV-6 during acute COVID-19 may help predict development of Long COVID

    Autoantibodies directed against neural targets have most predictive power.

  • iciHHV-6B linked to systemic lupus erythematosus (SLE) in Japanese and European populations

    iciHHV-6B, when integrated into chromosome 22q, was strongly associated with SLE and with SLE severity.

  • HHV-6 linked to miscarriage through Mendelian randomization studies

    The findings are consistent with previous studies directly linking HHV-6 endometrial infection to miscarriage.

  • Finnish investigators find unexpected evidence of HHV-6B integration into mitochondrial DNA

    Could HHV-6B infection exacerbate mitochondrial disease?

Newsletter | About Us | Contact Us | Donate | Repository

HHV-6 Foundation | HHV-6 Disease Information for Patients, Clinicians, and Researchers | Apply for a Grant Navigation
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter

Latest HHV-6 Research Articles

View Post

MicroRNA expression patterns suggest that HHV-6 may play a role in triggering systemic sclerosis

In All, Autoimmune Disease, Genes, Rash & Roseola by Kristin LoomisJuly 29, 2024

Expression pattern of several miRNAs in SS tissue parallels the pattern generated when dermal fibroblasts and endothelial cells are infected by HHV-6A and CMV.

View Post

Metformin reduces HHV-6A replication in T cells by activating AMPK

In All, Treatments - Antiviral by Kristin LoomisJune 25, 2024

Conversely, HHV-6A infection increases viral replication by inhibiting AMPK and enhancing mTOR signaling and glycolysis.

View Post

Could HHV-6 reactivation in drug hypersensitivity trigger fulminant type 1 diabetes?

In All, Autoimmune Disease, Drug Hypersensitivity by Kristin LoomisJune 25, 2024

Small study demonstrates increased HHV-6 antibodies in all patients shortly before the onset of DIHS-associated fulminant diabetes.

View Post

HHV-6B DNA associated with worse clinical outcomes in high grade serous epithelial ovarian cancer

In All, Cancer, Endocrine Conditions by Kristin LoomisJune 25, 2024

Multiplex assay for 113 viruses in tumor tissue finds six viruses, including HHV-6B, linked to reduced overall survival.

View Post

Reactivation of a transplant recipient’s iciHHV-6B resulted in an active infection of his donated liver

In All, ciHHV-6, iciHHV-6, Transplant Complications by Kristin LoomisJuly 5, 2024

Investigators from the University of Helsinki used highly sophisticated techniques to establish that the donor’s integrated virus reactivated and then infected the graft. This thorough investigation highlights the potential pathological impact of iciHHV-6B in transplantation.

View Post

Biofire multiplex PCR assay accurately detects HHV-6 meningitis/encephalitis in immunocompromised adults

In All, CNS Disease, iciHHV-6, Transplant Complications by Kristin LoomisJune 25, 2024

Utility of the assay in immunocompetent patients requires further study.

View Post

Could a specific polymorphism in HHV-6B partially explain the heritability of major depression?

In All, CNS Disease, Genes by Kristin LoomisApril 18, 2024

Individuals carrying this polymorphism had a five-fold increased risk of depression and were more likely to have a family member with major depression.

View Post

HHV-6A infection of thyroid cancer cells induces various growth-promoting changes

In All, Cancer, Endocrine Conditions by Kristin LoomisApril 18, 2024

Oncogene activation, pro-inflammatory cytokines, genomic instability, expression of oncogenic miRNAs are induced by infection.

View Post

Reactivated HHV-6, CMV, adenovirus and BK virus associated with increased mortality in pediatric sepsis

In All, Gastrointestinal, Transplant Complications by Kristin LoomisApril 18, 2024

Odds of mortality were 2.6-3X higher in patients with detectable viral DNA; odds were even higher with multiple herpesviruses.

View Post

Japanese study confirms cognitive problems from post-transplant HHV-6B reactivation

In All, Alzheimer's Disease, CNS Disease, Transplant Complications by Kristin LoomisApril 18, 2024

Those with the highest viral loads suffered deficits in verbal memory and reduced quality of life.

View Post

Antibodies to a protein specific to latent HHV-6B linked to ulcerative colitis flares

In All, Gastrointestinal by Kristin LoomisApril 1, 2024

Patients with elevated levels of antibodies to novel biomarker SITH-1 were significantly more likely to have disease activity.

View Post

HHV-7 found in the bronchial lavage of 6.2% of Chinese patients with severe pneumonia

In All, Lung Disease by Kristin LoomisApril 1, 2024

It is unknown whether high viral loads correlate with worse prognosis.

View Post

First careful characterization of rash in immunocompetent adults with HHV-7 viremia

In All, Rash & Roseola by Kristin LoomisApril 1, 2024

A distinctive maculopaular pattern involving the acral areas and sometimes the trunk.

View Post

Review: meningitis from HHV-7 appears clinically similar to that from HHV-6B, but less frequent

In All, Meningitis by Kristin LoomisApril 1, 2024

Of 32 patients, two had ocular complications and three had cerebral venous thrombosis.

View Post

Adding antithymocyte globulin to post transplant cyclophosphamide prophylaxis does not increase risk of HHV-6 reactivation after haploidentical hematopoietic cell transplantation

In All, Transplant Complications, Treatments - Antiviral, Treatments - Immune Stimulant by Kristin LoomisMarch 4, 2024

The main risk factor for HHV-6 reactivation was low absolute lymphocyte count.

  • Page 4 of 38
  • ←
  • 1
  • ...
  • 3
  • 4
  • 5
  • ...
  • 38
  • →

Clinical News

  • Alzheimer’s Disease
  • Animal Models
  • Autoimmune Disease
  • Cancer
  • iciHHV-6
  • CNS Disease
  • COVID-19 / HHV-6 Reactivation
  • Drug Hypersensitivity
  • Encephalitis & Encephalopathy
  • Endocrine Conditions
  • Epilepsy and Seizures
  • Gastrointestinal
  • Genes
  • Heart Disease
  • Hematological Disorders
  • HIV/AIDS Progression
  • Immunity & Immunotherapy
  • Infertility & Miscarriage
  • Kidney Disease
  • Liver Disease
  • Lung Disease
  • Lymphadenopathy & Fever
  • ME/CFS
  • Multiple Sclerosis
  • Rash & Roseola
  • Transplant Complications
  • Treatments – Adoptive T cell
  • Treatments – Alternative
  • Treatments – Antiviral
  • Treatments – Immune Stimulant

About HHV-6

  • What Is HHV-6?
  • What is Inherited Chromosomally Integrated HHV-6
  • HHV-6 Repository of Reagents
  • HHV-6A/B Testing
  • HHV-6 Treatment

SUBSCRIBE TO OUR NEWSLETTER

ABOUT THE HHV-6 FOUNDATION

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B.

The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge.

Read More

HHV-6 Foundation | 1482 East Valley Road, Suite 619 | Santa Barbara, CA, 93108 | Toll Free: (888) 530-6726


Copyright ©2004-2022 HHV-6 FOUNDATION


WEB DESIGN AND DEVELOPMENT BY INSTYLE TECHNOLOGIES
  • Home
  • About
  • Conditions
  • Clinicians
  • Testing
  • Research
  • Repository
  • Patients
  • Treatment
  • News & Blog
  • Donate
  • Contact Us
  • Cart
  • Checkout
  • Privacy Policy
  • Terms of Use